Axa S.A. Agios Pharmaceuticals, Inc. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Axa S.A. holds 238,750 shares of AGIO stock, worth $12.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

238,750

Previous 238,682 0.03%

Holding current value

$12.8 Million

Previous $10.3 Million 3.07%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $2,800 - $3,380	68 Added 0.03%	238,750 $10.6 Million
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $735,337 - $1.3 Million	-26,691 Reduced 10.06%	238,682 $10.3 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $1,577 - $2,575	74 Added 0.03%	265,373 $7.76 Million
Q4 2023 Jul 16, 2024	SELL	$19.97 - $24.53 $1,477 - $1,815	-74 Reduced 0.03%	265,299 $5.91 Million
Q4 2023 Feb 14, 2024	SELL	$19.97 - $24.53 $128,127 - $157,384	-6,416 Reduced 2.36%	265,299 $5.91 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $2.08 Million - $2.41 Million	-85,351 Reduced 23.9%	271,715 $6.72 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $41,797 - $57,066	1,955 Added 0.55%	357,066 $10.1 Million
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $111,569 - $158,732	-5,132 Reduced 1.42%	355,111 $8.16 Million
Q4 2022 Feb 14, 2023	SELL	$24.81 - $31.52 $35,776 - $45,451	-1,442 Reduced 0.4%	360,243 $10.1 Million
Q3 2022 Feb 14, 2023	BUY	$19.51 - $34.14 $3.21 Million - $5.62 Million	164,683 Added 83.59%	361,685 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $3.21 Million - $5.62 Million	164,683 Added 83.59%	361,685 $10.2 Million
Q2 2022 Feb 14, 2023	SELL	$17.06 - $31.42 $65,425 - $120,495	-3,835 Reduced 1.91%	197,002 $4.37 Million
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $65,425 - $120,495	-3,835 Reduced 1.91%	197,002 $4.37 Million
Q1 2022 Feb 14, 2023	SELL	$26.68 - $34.81 $4.29 Million - $5.6 Million	-160,848 Reduced 44.47%	200,837 $5.85 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $5.36 Million - $6.99 Million	200,837 New	200,837 $5.85 Million
Q1 2021 May 14, 2021	SELL	$44.23 - $57.5 $18.1 Million - $23.6 Million	-410,189 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.21 - $46.54 $1.15 Million - $1.62 Million	34,773 Added 9.26%	410,189 $17.8 Million
Q3 2020 Nov 13, 2020	BUY	$33.87 - $55.93 $2.16 Million - $3.57 Million	63,857 Added 20.5%	375,416 $13.1 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $2.52 Million - $3.91 Million	73,189 Added 30.7%	311,559 $16.7 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $1.22 Million - $2.08 Million	-38,582 Reduced 13.93%	238,370 $8.46 Million
Q4 2019 Feb 18, 2020	BUY	$30.08 - $50.59 $1.22 Million - $2.04 Million	40,420 Added 17.09%	276,952 $13.2 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $12,538 - $19,187	-387 Reduced 0.16%	236,532 $7.66 Million
Q2 2019 Aug 13, 2019	BUY	$46.17 - $68.1 $220,046 - $324,564	4,766 Added 2.05%	236,919 $11.8 Million
Q1 2019 May 14, 2019	BUY	$45.92 - $67.67 $197,456 - $290,981	4,300 Added 1.89%	232,153 $15.7 Million
Q4 2018 Feb 13, 2019	BUY	$42.73 - $76.53 $1.02 Million - $1.83 Million	23,869 Added 11.7%	227,853 $10.5 Million
Q3 2018 Nov 08, 2018	BUY	$71.67 - $91.95 $2.18 Million - $2.79 Million	30,368 Added 17.49%	203,984 $15.7 Million
Q2 2018 Aug 13, 2018	BUY	$73.22 - $99.55 $161,742 - $219,905	2,209 Added 1.29%	173,616 $14.6 Million
Q1 2018 May 14, 2018	SELL	$59.83 - $86.53 $103,505 - $149,696	-1,730 Reduced 1.0%	171,407 $14 Million
Q4 2017 Feb 13, 2018	BUY	$52.12 - $72.33 $593,855 - $824,128	11,394 Added 7.04%	173,137 $9.9 Million
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $8.88 Million - $10.9 Million	161,743	161,743 $10.8 Million

Others Institutions Holding AGIO

# of Institutions

234

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.95B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account